Edesa Biotech, Inc.
Biotechnology · MARKHAM, A6
BiotechnologySEC Form D
Edesa Biotech, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 26, 2026, reporting $3,499,986 raised toward a $3,500,000 offering.
Incorporated in British Columbia, Canada and based in MARKHAM, A6, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Edesa Biotech, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Sean MacDonaldDirector
- Pardeep NijhawanExecutive Officer · Director
- Carlo SistilliDirector
- Michael BrooksExecutive Officer
- Peter WeilerExecutive Officer
- Joan ChypyhaDirector
- Charles OlsonDirector
- Patrick MarshallDirector
- David LiuDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$19.1MRaised
Rapalogix Health, Inc.
$150.0KRaised
Chickadee Biomedicines, Inc.
$500.0KRaised
Boston Interactome, Inc.
$3.8MRaised
DINYA DNA, Inc.
$6.5MRaised